Omeros | OMER - Ordinary Share Capital


Omeros reported $611K in Ordinary Share Capital for its fiscal quarter ending in December of 2023.





Ordinary Share Capital Change Date
Adma Biologics USD 225.36M 6.93M Jun/2026
Alnylam Pharmaceuticals USD 133.88M 141K Sep/2026
BioMarin Pharmaceutical USD 193.54M 267K Jun/2026
Cytokinetics USD 138.76M 14.33M Jun/2026
Gilead Sciences USD 1.24B 1000K Jun/2026
Heron Therapeutics USD 188.31M 4.99M Dec/2025
Immunic USD 120.38M 21.73M Dec/2025
Insmed USD 218.28M 1.76M Jun/2026
Knight Therapeutics CAD 99.68M 24.66K Sep/2025
MacroGenics USD 63.65M 86K Jun/2026
Omeros USD 611K 17K Dec/2023
Pacira USD 39.82M 512K Jun/2026
Pfizer USD 5.7B 0 Jun/2026
Sarepta Therapeutics USD 107.23M 1.61M Sep/2026
United Therapeutics USD 42.38M 295K Sep/2026
Vertex Pharmaceuticals USD 253.5M 200K Sep/2026